Shasun Pharma announces completion of US FDA and Mexican COFEPRIS inspection
At its API facility at Cuddalore, Tamil Nadu
Shasun Pharmaceuticals announced that the Company has successfully completed the US FDA and Mexican COFEPRIS inspection at its API facility at Cuddalore, Tamil Nadu, IndiaPowered by Capital Market - Live News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 08 2014 | 11:49 AM IST